1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Travel Vaccines Market 2016-2020

Global Travel Vaccines Market 2016-2020

  • November 2016
  • -
  • Infiniti Research Limited
  • -
  • 60 pages

About Travel Vaccines
As the world continues to move toward globalization, the international travels will keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan. The market is growing because various government bodies have mandated the immunization of travelers visiting the infectious-prone areas with various types of vaccines. This, in turn, prevents the spread of infection and averts any chances of epidemic outbreaks.

Technavio’s analysts forecast the global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020.


Covered in this report

The report covers the present scenario and the growth prospects of the global travel vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various vaccines administered to actively immunize meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.


The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

Technavio's report, Global Travel Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors

- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi


Other prominent vendors

- Abbott
- AstraZeneca
- Bavarian Nordic
- Baxter
- Beijing Minhai Biotechnology
- Bharat Biotech
- Bharat Immunologicals and Biologicals
- Bio-Med
- Seqirus CSL
- Crucell
- CSL
- Dynavax Technologies
- Emergent BioSolutions
- GlycoVaxyn
- GreenSignal Bio Pharma
- Hualan Biological Engineering
- Imunoloski Zavod
- Indian Immunologicals
- Janssen Pharmaceuticals
- JN International Medical
- Kaketsuken
- LG Life Sciences
- Lupin
- Mitsubishi Tanabe Pharma
- Novavax
- Nuron Biotech
- Panacea Biotec
- Pfizer
- Protein Sciences
- Roche
- SK Chemicals
- Serum Institute of India
- Shenzhen Kangtai Biological Products
- Sinovac Biotech
- Takeda Pharmaceutical
- Vacunas Finlay
- Valeant Pharmaceuticals
- Valneva,
- Zydus Cadila


Market driver

- Growing demand among travelers
- For a full, detailed list, view our report


Market challenge

- Requires specific storage and distribution system
- For a full, detailed list, view our report


Market trend

- Combination vaccines
- For a full, detailed list, view our report


Key questions answered in this report

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.







Methodology
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Table Of Contents

Global Travel Vaccines Market 2016-2020
Table of Contents
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Regulatory scenario of vaccines
PART 06: Market landscape
- Market overview
- Five forces analysis
PART 07: Market segmentation by disease type
PART 08: Market segmentation by composition
- Mono vaccines
- Combination vaccines
PART 09: Geographical segmentation
- Travel vaccines market in Americas
- Travel vaccines market in EMEA
- Travel vaccines market in APAC
PART 10: Market drivers
- Growing demand among travelers
- Additional age group approval
- Inclusion in NIP
PART 11: Impact of drivers
PART 12: Market challenges
- Requires specific storage and distribution system
- High risk and cost involved in vaccine development
- Stringent regulatory guidelines
PART 13: Impact of drivers and challenges
PART 14: Market trends
- Combination vaccines
- Increase in RandD activities
- Public-private initiatives
PART 15: Vendor landscape
- Competitive scenario
- Other prominent vendors
PART 16: Key vendor analysis
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi
PART 17: Appendix
- List of abbreviations
PART 18: Explore Technavio


List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Market share of travel vaccines markets in global pharmaceutical market 2015
Exhibit 03: Market share of travel vaccines markets in global pharmaceutical market, 2015
Exhibit 04: Country/region-specific vaccination
Exhibit 05: Key buying criteria for travel vaccines 2015
Exhibit 06: Impact of key customer segments on market 2015
Exhibit 07: Requirements for a BLA submission
Exhibit 08: Stages of vaccine development to obtain license
Exhibit 09: Processes involved in the vaccine development
Exhibit 10: Regulatory testing of licensed vaccines
Exhibit 11: Market snapshot: Global travel vaccines market
Exhibit 12: Worldwide endemicity of HAV infection
Exhibit 13: Endemicity pattern of HBV across various regions
Exhibit 14: Global travel vaccine market snapshot: Developed and emerging markets 2015
Exhibit 15: Overview of vaccine-related acquisitions (2005-2012)
Exhibit 16: Global travel vaccines market 2015-2020 ($ billions)
Exhibit 17: Few of approved travel vaccines
Exhibit 18: Vaccine recommendation for travelers
Exhibit 19: Five forces analysis
Exhibit 20: Market segmentation of travel vaccines based on disease type 2015
Exhibit 21: Market share of the different types of travel vaccines based on disease type 2015
Exhibit 22: Overview of global travel vaccines market segmentation based on disease type 2015-2020
Exhibit 23: Global travel vaccines market segmentation by composition
Exhibit 24: Details of approved polysaccharide vaccines
Exhibit 25: Snapshot of global travel vaccines market by geography 2015-2020
Exhibit 26: Global travel vaccines market segmentation by geography 2015-2020 ($ millions)
Exhibit 27: Overview of travel vaccines market in Americas
Exhibit 28: Recommended vaccination for travelers to Mexico
Exhibit 29: Recommended vaccination for travelers to Brazil
Exhibit 30: Travel vaccines market in Americas 2015-2020 ($ billions)
Exhibit 31: Overview of travel vaccines market in EMEA
Exhibit 32: Outbreaks of measles in EMEA during 2011
Exhibit 33: Recommended vaccination for travelers to Italy
Exhibit 34: Recommended vaccinations for travelers to France
Exhibit 35: Recommended vaccinations for some travelers to South Africa
Exhibit 36: Travel vaccines market in EMEA 2015-2020 ($ millions)
Exhibit 37: Overview of travel vaccines market in APAC
Exhibit 38: Recommended vaccination for travelers to India
Exhibit 39: Recommended vaccination for travelers to China
Exhibit 40: Travel vaccines market in APAC 2015-2020 ($ millions)
Exhibit 41: Impact of drivers and challenges on global travel vaccines market
Exhibit 42: Impact of drivers
Exhibit 43: A typical cold chain process
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Impact of trends on global travel vaccines market
Exhibit 46: Competitive structure analysis of global travel vaccines market 2015
Exhibit 47: Key vendors: Geographical presence 2015
Exhibit 48: Competitive assessment of vendors
Exhibit 49: GlaxoSmithKline: Key highlights
Exhibit 50: GlaxoSmithKline: Strength assessment
Exhibit 51: GlaxoSmithKline: Strategy assessment
Exhibit 52: GlaxoSmithKline: Opportunity assessment
Exhibit 53: Merck: Key highlights
Exhibit 54: Merck: Strength assessment
Exhibit 55: Merck: Strategy assessment
Exhibit 56: Merck: Opportunity assessment
Exhibit 57: Pfizer: Key highlights
Exhibit 58: Pfizer: Strength assessment
Exhibit 59: Pfizer: Strategy assessment
Exhibit 60: Pfizer: Opportunity assessment
Exhibit 61: Sanofi: Key highlights
Exhibit 62: Sanofi: Strength assessment
Exhibit 63: Sanofi: Strategy assessment
Exhibit 64: Sanofi: Opportunity assessment


Companies Mentioned
GlaxoSmithKline, Merck, Pfizer, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Baxter, Beijing Minhai Biotechnology, Bharat Biotech, Bharat Immunologicals and Biologicals, Bio-Med, Seqirus CSL, Crucell, CSL, Dynavax Technologies, Emergent BioSolutions, GlycoVaxyn, GreenSignal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Protein Sciences, Roche, SK Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Takeda Pharmaceutical, Vacunas Finlay, Valeant Pharmaceuticals, Valneva, Zydus Cadila.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Travel Intermediaries Business, 2011 to 2020

Global Travel Intermediaries Business, 2011 to 2020

  • $ 14995
  • Industry report
  • October 2016
  • by Canadean Ltd

Summary Travel Intermediaries (part of a business that assists in selling travel products and services to customers, which may include airline tickets, car rentals, hotels, railway tickets, and package ...

Travel Intermediaries Business in Europe, 2011 to 2020

Travel Intermediaries Business in Europe, 2011 to 2020

  • $ 7995
  • Industry report
  • October 2016
  • by Canadean Ltd

Summary Travel Intermediaries (part of a business that assists in selling travel products and services to customers, which may include airline tickets, car rentals, hotels, railway tickets, and package ...

Travel Intermediaries Business in Asia-Pacific, 2011 to 2020

Travel Intermediaries Business in Asia-Pacific, 2011 to 2020

  • $ 5995
  • Industry report
  • October 2016
  • by Canadean Ltd

Summary Travel Intermediaries (part of a business that assists in selling travel products and services to customers, which may include airline tickets, car rentals, hotels, railway tickets, and package ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.